Abstract: The present disclosure describes the use of sodium channel blockers such as tetrodotoxin or saxitoxin, its analogs/derivatives as well as their acceptable salts, for treating neuropathic pain resulting from chemotherapy. Methods, compositions, dose units and dose forms of tetrodotoxin related to the use are described.

Abstract: The present disclosure describes the use of sodium channel blockers such as tetrodotoxin or saxitoxin, its analogues/derivatives as well as their acceptable salts, for treating neuropathic pain resulting from chemotherapy. Methods, compositions, dose units and dose forms of tetrodotoxin related to the use are described.

Abstract: A method for use in providing video to a user includes establishing digital video data that includes images shot in relation to a making of content, uploading the digital video data to a server, and sending the digital video data from the server through a network to a client device for viewing by the user. The client device may be configured to allow the user to mark one or more portions of the digital video data for review or deletion. A system for use in providing video to a user is also disclosed.

Abstract: The present disclosure generally teaches compositions comprising SDF-1 mimetics and methods of using them to modulate an activity of a cell having an SDF-1 receptor by binding the SDF-1 receptor to an SDF-1 mimetic. The cell can be a hematopoietic cell, for example, and can be selected from a group consisting of hematopoietic stem cells, hematopoietic progenitor cells, primitive granulocytes, primitive erythroid cells, leukocytes, and neutrophils. In some embodiments, the activity can include the rate of multiplication of the cell or, where the cell is a quiescent cell, the binding can repress the activation of the quiescent cell. Other embodiments of the present invention are taught herein.

Abstract: The present disclosure generally teaches compositions comprising SDF-1 mimetics and methods of using them to modulate an activity of a cell having an SDF-1 receptor by binding the SDF-1 receptor to an SDF-1 mimetic. The cell can be a hematopoietic cell, for example, and can be selected from a group consisting of hematopoietic stem cells, hematopoietic progenitor cells, primitive granulocytes, primitive erythroid cells, leukocytes, and neutrophils. In some embodiments, the activity can include the rate of multiplication of the cell or, where the cell is a quiescent cell, the binding can repress the activation of the quiescent cell. Other embodiments of the present invention are taught herein.

Abstract: A method for use in providing video to a user includes establishing digital video data that includes images shot in relation to a making of content, uploading the digital video data to a server, and sending the digital video data from the server through a network to a client device for viewing by the user. The client device may be configured to allow the user to mark one or more portions of the digital video data for review or deletion. A system for use in providing video to a user is also disclosed.

Abstract: This invention is directed to peptide analogs of interferon-inducible protein-10 (IP-10 or CXCL10) chemokine that bind to the CXCR3 receptor or any other receptor in which IP-10 analogs can bind to as a ligand, such that the analogs can be designed to serve as agonists or antagonists of IP-10 chemokine. The analogs can be used to prevent, treat, or ameliorate the symptoms of, a disease.

Abstract: The present invention is concerned with chemokine analogs, including IL-8 analogs, IP-10 analogs, MIP-1? analogs, RANTES analogs, I-309 analogs, MCP-1 analogs, and CCL28 analogs, that are useful for the treatment of a variety of diseases and disorders, and as an adjunct to the treatment of a variety of diseases and disorders. A therapeutically effective amount of the chemokine analog may be administered to a patient in need of such treatment.

Abstract: The present disclosure generally teaches compositions comprising SDF-1 mimetics and methods of using them to modulate an activity of a cell having an SDF-1 receptor by binding the SDF-1 receptor to an SDF-1 mimetic. The cell can be a hematopoietic cell, for example, and can be selected from a group consisting of hematopoietic stem cells, hematopoietic progenitor cells, primitive granulocytes, primitive erythroid cells, leukocytes, and neutrophils. In some embodiments, the activity can include the rate of multiplication of the cell or, where the cell is a quiescent cell, the binding can repress the activation of the quiescent cell. Other embodiments of the present invention are taught herein.

Abstract: The present invention teaches compositions and uses of mimetics of IL-8 in the diagnosis, prevention, treatment, and ameliorization of symptoms of a variety of diseases.

Abstract: A method for detecting microorganisms includes obtaining a sample from a source of interest and applying the sample to a selective growth medium to permit any microorganisms of interest in the sample to grow. Any microorganisms that have grown are harvested. An immunoassay is then conducted to detect the microorganism of interest, if any, with a high degree of sensitivity and specificity. A system that may be used to grow, harvest, and detect a microorganism of interest includes a growth plate, or dish, a lavage solution, a lavage apparatus, and an assay apparatus. The dish may include a vessel with multiple sections, at least one of which is used to grow microorganisms of interest, and another of which is configured to receive and contain harvested microorganisms of interest.

Abstract: The present invention is concerned with chemokine analogs, including IL-8 analogs, IP-10 analogs, MIP-1? analogs, RANTES analogs, I-309 analogs, MCP-1 analogs, and CCL28 analogs, that are useful for the treatment of a variety of diseases and disorders, and as an adjunct to the treatment of a variety of diseases and disorders. A therapeutically effective amount of the chemokine analog may be administered to a patient in need of such treatment.

Abstract: The present invention is concerned with chemokine derived analogs, including SDF-1 and/or SDF-1/MIP1? hybrid analogs, that are useful for the treatment of a variety of diseases and disorders, and as an adjunct to the treatment of a variety of diseases and disorders. A therapeutically effective amount of the chemokine analog may be administered to a patient in need of such treatment.

Abstract: The present invention is concerned with chemokine analogs, including IL-8 analogs, IP-10 analogs, MIP-1&agr; analogs, RANTES analogs, I-309 analogs, MCP-1 analogs, and CCL28 analogs, that are useful for the treatment of a variety of diseases and disorders, and as an adjunct to the treatment of a variety of diseases and disorders. A therapeutically effective amount of the chemokine analog may be administered to a patient in need of such treatment.

Abstract: A networked computer online gaming system and process arranged in a client/server online gaming architecture and utilized to run gaming programs. The client computers are configured to run a gaming client program. The server computers are coupled to the client computers via a network. The server computers run server programs including a master control program (MCP) that governs access of the server programs to the online gaming architecture, a servorum program (SV) for creating instances of a server program, a matchmaker program (MM) that supports rendezvous services, a game instances class server program (GICS) that enables games and provides user to user communication, and game upper level protocol server program (GULP) that supports the user to user communication provided by said GICS.